Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

China is starting clinical trials of a Covid vaccine that can be inhaled
China is starting clinical trials of a Covid vaccine that can be inhaled
China’s CanSino Biologics will be starting clinical trials for a Covid-19 vaccine that is administered through inhalation next week, the company’s co-founder and Chief Executive Xuefeng Yu told CN...
Indian pharma exports grow at 18% to $24.44 billion in FY 21 from $20.58 bn
Indian pharma exports grow at 18% to $24.44 billion in FY 21 from $20.58 bn
Pharma exports from India witnessed over 18 per cent growth to USD 24.
Merck Drops $425 Million COVID-19 Drug, Refocusing on Another Candidate
Merck Drops $425 Million COVID-19 Drug, Refocusing on Another Candidate
In November 2020, Merck plunked down $425 million in upfront cash to acquire OncoImmune and its Phase III COVID-19 therapeutic asset candidate CD24Fc.
Sanofi setting up its 1st research institute in China
Sanofi setting up its 1st research institute in China
French pharmaceutical company Sanofi announced the establishment of Sanofi Institute for Biomedical Research, its first global research institute in China, in Suzhou, Jiangsu province, neighboring Sha...
Sinopharm to inject $4.6 bln vaccine assets into unit Tiantan Biological
Sinopharm to inject $4.6 bln vaccine assets into unit Tiantan Biological
Chinese state-owned Sinopharm plans to inject 30 billion yuan ($4.
Thermo Fisher expands pharma service business with $17.4 bln PPD acquisition
Thermo Fisher expands pharma service business with $17.4 bln PPD acquisition
Medical device maker Thermo Fisher Scientific Inc (TMO.
FDA Approves First Drug for Group 3 PH
FDA Approves First Drug for Group 3 PH
People with Group 3 pulmonary hypertension (PH) associated with interstitial lung disease now have a Food and Drug Administration (FDA)-approved treatment option.
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Today, the U.
Abzena To Create 325 Jobs In North Carolina
Abzena To Create 325 Jobs In North Carolina
Abzena, a life sciences contract development and manufacturing organization (CDMO), will invest $213 million to open a new facility in Sanford, NC.
Novel antibiotic deceives bacteria through mimicry
Novel antibiotic deceives bacteria through mimicry
Most antibiotics need to penetrate their target bacteria.
New discovery could lead to therapies for patients with Duchenne muscular dystrophy
New discovery could lead to therapies for patients with Duchenne muscular dystrophy
Irvine, CA - April 14, 2021 - A new study, led by the University of California, Irvine (UCI), reveals how chronic inflammation promotes muscle fibrosis, which could inform the development of n...
Alnylam faces DOJ probe over Onpattro marketing
Alnylam faces DOJ probe over Onpattro marketing
In the competitive market to sell drugs for the rare disease hereditary ATTR amyloidosis, the Justice Department thinks Alnylam may have crossed a line.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand